Skip to content
Recall Observatory FDA recall evidence

Drug product

Moxifloxacin Ophthalmic Solution USP, 0.5%, 5 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Pithampur (M.P.) 454 775, INDIA, NDC 68180-422-01

D-1050-2018

July 26, 2018

Class III

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 80668
Status
Terminated
Classification
Class III
Quantity
13,896 bottles
Official record key
drug-enforcement:D-1050-2018

Official wording

Reason: Failed Impurities/Degradation Specifications: An out-of-specification result in the related substance test during three month long-term stability study.

Code information: Lot #: H800393, Exp. 01/2020

Distribution pattern: Product was distributed throughout the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out-of-specification